Pres. Donald Trump is expected to issue an executive order on Monday in Washington to reclassify marijuana as a lesser ...

Industry members are cautiously optimistic that rescheduling marijuana to a lower tier is one step closer to full ...

Using an executive order, he opened up research possibilities and eased taxes for businesses. But does it go far enough?

Medical marijuana would likely expand for consumers. The bad: Big Pharma might squash the small guys. The ugly: No one agrees.

Journalist Andy Lyman with the Lesser Known New Mexico podcast spoke with the founder of Verdes Cannabis in Albuquerque, Eric Seegle, about what a recent executive order that could reclassify ...

President Trump signed an executive order Thursday to reclassify marijuana from a Schedule I to Schedule III drug, a move ...

Trump's executive order moves marijuana to Schedule III, affecting 6 million patients. Cannabis stocks plunge 27% amid fears ...

Cannabis and hemp THC companies stand to benefit if marijuana is reclassified to Schedule 3, but banking and investment needs ...

President Donald Trump issued an executive order Thursday reclassifying marijuana as a Schedule III controlled substance, a ...

Insys Therapeutics is having a bad run. The Arizona-based pharmaceutical company’s stock is down 50 percent from its peak in August. In that time, sales have slumped by tens of millions of dollars—and ...

Some cannabis stocks are outperforming despite a weak sector, with legalization catalysts and market positioning driving ...